Repare Therapeutics Inc. Current Foreign Tax Expense (Benefit)
Repare Therapeutics Inc. reported Current Foreign Tax Expense (Benefit) of $1.44 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2025-03-03
- Repare Therapeutics Inc. current foreign tax expense (benefit) for fiscal 2024 was $1.44M.
- Repare Therapeutics Inc. current foreign tax expense (benefit) for fiscal 2023 was -$9.38M, a 181.40% decline from fiscal 2022.
- Repare Therapeutics Inc. current foreign tax expense (benefit) for fiscal 2022 was $11.53M, a 2074.91% increase from fiscal 2021.
- Repare Therapeutics Inc. current foreign tax expense (benefit) for fiscal 2021 was $530.00K.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $1.44M 10-K · filed 2025-03-03 |
| 2023-12-31 | -$9.38M 10-K · filed 2025-03-03 |
| 2022-12-31 | $11.53M 10-K · filed 2024-02-28 |
| 2021-12-31 | $530.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | -$45.00K 10-K · filed 2022-03-01 |
| 2019-12-31 | $327.00K 10-K · filed 2022-03-01 |